Weige Wang

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL

Sabah Kadri, Jimmy Lee, Carrie Fitzpatrick et al. · Blood Advances · 2017 · 132 citations · Full text

Medicine, Genetics, Oncology +17

Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL

Shruti Sharma, Natalie Galanina, Ailin Guo et al. · Oncotarget · 2016 · 89 citations · Full text

Medicine, Molecular Biology, Oncology +16

Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells

Yanchun Wang, Zhongguang Luo, Yongfu Pan et al. · Cancer Biology & Therapy · 2015 · 56 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB

Mei Ming, Wenjun Wu, Bingqing Xie et al. · Molecular Cancer Therapeutics · 2018 · 47 citations

Medicine, Oncology, Pharmacology +17

Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma

Wenli Cui, Ying Cai, Weige Wang et al. · Journal of Translational Medicine · 2014 · 44 citations · Full text

Medicine, Molecular Biology, Oncology +16